Characterization of single neurons reprogrammed by pancreatic cancer
Vera Thiel, Simon Renders, Jasper Panten et al. · Nature · 2025
Full textCC BY
Psychiatry and Mental health
Filters2 filters applied
Status
Year
Readable here
Study type
Licence
212 papers7 CorrectedQuestions on this topic
The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging
Farhad Imam, Rowan Saloner, Jacob W. Vogel et al. · Nature Medicine · 2025
Full textCC BY
Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology
Nicholas J. Ashton, Wagner S. Brum, Guglielmo Di Molfetta et al. · JAMA Neurology · 2024
Full textCC BY
Corrected Brain clocks capture diversity and disparities in aging and dementia across geographically diverse populations
Sebastian Moguilner, Sandra Baez, Hernan Hernandez et al. · Nature Medicine · 2024
Full textCC BY
Alzheimer's disease: a comprehensive review of epidemiology, risk factors, symptoms diagnosis, management, caregiving, advanced treatments and associated challenges
Saeid Safiri, Amir Ghaffari Jolfayi, Asra Fazlollahi et al. · Frontiers in Medicine · 2024 · Review
Full textCC BY
Mitigating the Associations of Kidney Dysfunction With Blood Biomarkers of Alzheimer Disease by Using Phosphorylated Tau to Total Tau Ratios
Shorena Janelidze, Nicolas R. Barthélemy, Yingxin He et al. · JAMA Neurology · 2023
Full textCC BY
Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers
Niklas Mattsson-Carlgren, Gemma Salvadó, Nicholas J. Ashton et al. · JAMA Neurology · 2023
Full textCC BY
Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology
Jonathan P Rogers, Mark A Oldham, Gregory Fricchione et al. · Journal of Psychopharmacology · 2023
Full textCC BY
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications
Fernando Gonzalez-Ortiz, Przemysław R. Kac, Wagner S. Brum et al. · Molecular Neurodegeneration · 2023 · Review
Full textCC BY
Genes4Epilepsy : An epilepsy gene resource
Karen L. Oliver, Ingrid E. Scheffer, Mark F. Bennett et al. · Epilepsia · 2023
Full textCC BY
The use of neuroimaging techniques in the early and differential diagnosis of dementia
Leonidas Chouliaras, John T. O’Brien · Molecular Psychiatry · 2023 · Review
Full textCC BY
The synaptic hypothesis of schizophrenia version III: a master mechanism
Oliver D. Howes, Ellis Chika Onwordi · Molecular Psychiatry · 2023 · Review
Full textCC BY
The effect of social relationships on cognitive decline in older adults: an updated systematic review and meta-analysis of longitudinal cohort studies
Matteo Piolatto, Federico Bianchi, Matteo Rota et al. · BMC Public Health · 2022 · Meta-analysis
Full textCC BY
Normal Aging Induces Changes in the Brain and Neurodegeneration Progress: Review of the Structural, Biochemical, Metabolic, Cellular, and Molecular Changes
Jiseon Lee, Hee-Jin Kim · Frontiers in Aging Neuroscience · 2022 · Review
Full textCC BY
IL-17 crosses the blood–brain barrier to trigger neuroinflammation: a novel mechanism in nitroglycerin-induced chronic migraine
Hao Chen, Xueqian Tang, Jin Li et al. · The Journal of Headache and Pain · 2022
Full textCC BY
Cardiometabolic multimorbidity, genetic risk, and dementia: a prospective cohort study
Xin You Tai, Michele Veldsman, Donald M Lyall et al. · The Lancet Healthy Longevity · 2022
Full textCC BY
The economic burden of dementia in low- and middle-income countries (LMICs): a systematic review
Siti Maisarah Mattap, Devi Mohan, Andrea Mary McGrattan et al. · BMJ Global Health · 2022 · Systematic review
Full textCC BY
Brain ageing in schizophrenia: evidence from 26 international cohorts via the ENIGMA Schizophrenia consortium
Constantinos Constantinides, Laura K. M. Han, Clara Alloza et al. · Molecular Psychiatry · 2022 · Meta-analysis
Full textCC BY
Association of Pace of Aging Measured by Blood-Based DNA Methylation With Age-Related Cognitive Impairment and Dementia
Karen Sugden, Avshalom Caspi, Maxwell L. Elliott et al. · Neurology · 2022
Full textCC BY
Racial and Ethnic Differences in Amyloid PET Positivity in Individuals With Mild Cognitive Impairment or Dementia
Consuelo H. Wilkins, Charles C. Windon, Peggye Dilworth-Anderson et al. · JAMA Neurology · 2022
Full textCC BY